禁室培欲3:香港情夜,日本一区二区在线播放,国产一区二区三区在线观看,亚洲天天做日日做天天爽

歡迎來到凱學生物科技(上海)有限公司網站!

熱門關鍵詞:進口ELISA試劑盒,人ELISA試劑盒,大鼠elisa試劑盒價格,小鼠elisa試劑盒價格,豬elisa試劑盒,雞elisa試劑盒,兔elisa試劑盒,魚elsa試劑盒,其他種屬elisa試劑盒,豚鼠elisa試劑盒,倉鼠elisa試劑盒,裸鼠ELISA試劑盒,進口試劑,血清,動物血清,人血清,胎牛血清,氨基酸試劑,培養基,顯色培養基,大腸桿菌O157培養基,細菌總數培養基,金黃色葡萄球菌檢驗培養基,沙門氏菌/賀氏菌檢驗培養基, 弧菌檢驗培養基,其他培養基,酵母 霉菌 青霉 曲霉培養基, 李斯特氏菌檢驗培養基,抗體,二抗,一抗,生物試劑,酶生物試劑,蛋白質試劑,抗生素試劑,植物激素及核酸試劑,碳水化合物試劑,色素試劑,維生素試劑,表面活性劑,緩沖試劑,其他生化試劑,標準品對照品類,對照品,對照藥材,標準品,標準試劑,Spectrum試劑,美國藥典級試劑等

新聞中心您現在的位置:首頁 > 新聞中心 > IBL

IBL

更新時間:2013-01-11   點擊次數:2204次

IBL International and Leiden University Medical Centre sign exclusive licence agreement for innovative Myasthenia gravis diagnostics

 

Hamburg, June 1st, 2012.

IBL International, a leader in the development, production and distribution of immunodiagnostic products, announced today that it has obtained an exclusive, worldwide licence from Leiden University Medical Centre (LUMC) to manufacture and sell an ELISA assay for the detection of MuSK antibodies for the diagnosis of patients with Myasthenia gravis.

Myasthenia gravis (MG) is a severe autoimmune neuromuscular disease often caused by acetylcholine receptor antibodies which block proper signalling between neurons and muscle. However, some 20% of patients with generalized MG and up to 50% of patients with ocular MG show no detectable antibodies to the acetylcholine receptor (“seronegative” MG). The muscle-specific receptor tyrosine kinase (MuSK) plays an essential role in the neuromuscular junction, and MuSK-blocking antibodies have been found in about 50% of seronegative MG patients. MuSK MG patients are mostly female, have prominent cranial and bulbar involvement, and the onset of the disease tends to be at an early age, though the elderly can be affected as well. A new ELISA method has now been developed at LUMC by Prof. van der Maarel and Prof. Verschuuren: the first to provide rapid, nonradioactive identification and quantification of MuSK antibodies in human serum. Measurement of MuSK antibodies will substantially improve diagnosis and clinical management of Myasthenia gravis.

For more than 15 years IBL has been offering the gold standard in serological diagnosis of MG: a radioactive assay for the detection of acetylcholine-receptor autoantibodies (ARAb). That assay is now complemented by the new (and validated) MuSK ELISA, for which recently obtained CE registration. Jan Boesen, CEO of International says: “The MuSK ELISA will strengthen our expertise and enhance our portfolio of biomarkers for the diagnosis of MG; it creates added value, because nearly 95% of MG patients can be detected now that we have both assays”.

For more information please contact:

International GmbH:

Dirk Böttcher, Head of Finance

Phone : +49 (0)40-53 28 91-0

: Dirk.Boettcher@-International.com

www.ibl-international.com

International GmbH in Hamburg belongs to a Netherlands holding company and provides one of the widest ranges of immunoassays for special diagnostics used in research and routine laboratories. Most of its products are based on immunoassay

technology. International has a direct sales organization in Germany, the Netherlands and the US, and a worldwide international distribution network.

Leiden University Medical Centre (LUMC) focuses on top quality highly specialised clinical care including complex medical issues for which there are often no answers as yet. With atient care and research labs under one roof, patients, doctors and researchers work together to develop new treatment methods. The LUMC also offers teaching courses and continuing education for doctors and other medical specialists.